Patents by Inventor Valerie A. Vaillancourt

Valerie A. Vaillancourt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocycle carboxamides as antiviral agents
    Publication number: 20020025959
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 28, 2002
    Inventors: David John Anderson, Thomas J. Beauchamp, Gordon L. Bundy, Fred L. Ciske, John R. Farrell, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Robert Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20020019397
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 14, 2002
    Applicant: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
    Publication number: 20020019413
    Abstract: The present invention provides a compound of Formula III 1
    Type: Application
    Filed: March 15, 2001
    Publication date: February 14, 2002
    Inventors: Valerie A. Vaillancourt, Atli Thorarensen
  • 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
    Publication number: 20020007066
    Abstract: A compound of formula IV: 1
    Type: Application
    Filed: March 15, 2001
    Publication date: January 17, 2002
    Inventor: Valerie A. Vaillancourt
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6329545
    Abstract: The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: December 11, 2001
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6274580
    Abstract: Compounds selected from the group consisting of formulae I, II, III, IV, VI, VII, and VIII wherein R is H or NH2, and pharmacologically acceptable salts thereof, are suitable for use in methods for treating non-insulin-dependent diabetes mellitus (NIDDM) or obesity in a patient susceptible to or experiencing NIDDM or obesity by the systemic administration of such a compound in an amount effective to treat the NIDDM or obesity.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: August 14, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May
  • Quinolinecarboxamides as antiviral agents
    Patent number: 6248739
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, John Alan Tucker
  • 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
    Patent number: 6248736
    Abstract: The present invention provides a compound of formula I Wherein R1 is C1-7 alkyl, optionally substituted by hydroxy or NR4R5; R2 is C1-7 alkyl substituted by hydroxy or NR4R5; R3 is H, F or C1-7 alkoxy; R4 and R5 together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof Compounds of formula I of the present invention are useful as antiviral agents.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, Allen Scott
  • Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6184216
    Abstract: Compounds selected from the group consisting of formulae III, IV, VI and VIII wherein R is H is NH2, or a pharmacologically acceptable salt thereof, are suitable for use in methods for treating non-insulin-dependent diabetes mellitus (NIDDM) or obesity in a patient susceptible to or experiencing NIDDM or obesity by the systemic administration of such a compound in an amount effective to treat the NIDDM or obesity.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: February 6, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May
  • Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6177453
    Abstract: The present invention provides for the treatment of non-insulin dependent diabetes mellitus or obesity comprising the systemic administration of a compound having the formula or a pharmacologically acceptable salt thereof, wherein each R is H or NH2, and with the proviso that at least one R group must be NH2.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: January 23, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May
  • Aminoquanidine carboxylates for the treatment of obesity
    Patent number: 6166080
    Abstract: The present invention provides novel compounds of the formulae (I): AG--(CH.sub.2).sub.n --CO.sub.2 R.sup.1 and (II) or pharmacologically acceptable salts thereof, wherein AG is: a) N-aminoguanidine, b) N,N'-diaminoguanidine, or c) N,N',N"-triaminoguanidine; and n, R.sup.1 and R.sup.2 have the meanings given in the description as well as a new use for the compounds of formula (III) wherein R.sup.3 has the meanings given in the description for the treatment of non-insulin dependent diabetes mellitus (NIDDM).
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: December 26, 2000
    Assignee: Pharmacia
    Inventors: Scott D. Larsen, Paul D. May, Steven P. Tanis, Valerie A. Vaillancourt, John A. Tucker, Heinrich J. Schostarez, Martin D. Meglasson
  • 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
    Patent number: 6093732
    Abstract: The present invention provides 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula I ##STR1## These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: July 25, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: John Alan Tucker, Valerie A. Vaillancourt, Joseph Walter Strohbach, Karen Rene Romines, Mark E. Schnute, Michele M. Cudahy, Suvit Thaisrivongs, Steven Ronald Turner
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 5994577
    Abstract: The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 5955617
    Abstract: The present invention provides novel compounds of the formulae I-VIII for the treatment of non-insulin dependent diabetes mellitus (NIDDM) and a new use of known compounds IX to X for this purpose.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: September 21, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May